NYSE:DNMR
Danimer Scientific, Inc.
- Stock
Last Close
0.74
02/05 19:59
Market Cap
69.65M
Beta: 1.50
Volume Today
503.47K
Avg: 1.58M
PE Ratio
−0.43
PFCF: −0.68
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -19.51M - | -12.57M 35.57% | -60.11M 378.06% | -179.76M 199.06% | -155.47M 13.51% | |
depreciation and amortization | 4.07M - | 5.12M 25.90% | 10.63M 107.57% | 20.09M 88.88% | 29.06M 44.67% | |
deferred income tax | 4.14M - | -5.28M 227.51% | -13.23M 150.86% | -814K 93.85% | -199K 75.55% | |
stock based compensation | 5.27M - | 3.65M 30.85% | 55.27M 1,416.32% | 56.96M 3.05% | 56.03M 1.62% | |
change in working capital | 8.68M - | -7.18M 182.69% | -28.87M 302.09% | -19.32M 33.09% | -1.11M 94.27% | |
accounts receivables | 2.19M - | -1.60M 172.89% | -10.84M 577.19% | -3.06M 71.80% | -1.42M 53.47% | |
inventory | -2.99M - | -6.60M 120.65% | -9.80M 48.38% | -11.17M 13.99% | 949K 108.50% | |
accounts payables | 3.63M - | 993K 72.68% | 2.05M 106.24% | -1.56M 176.42% | -635K 59.42% | |
other working capital | 5.85M - | 30K 99.49% | -10.29M 34,393.33% | -3.53M 65.69% | 1.11M 131.39% | |
other non cash items | -4.32M - | 2.46M 157.04% | -26.65M 1,181.70% | 61.01M 328.91% | 23.32M 61.79% | |
net cash provided by operating activities | -1.67M - | -13.80M 724.69% | -62.96M 356.35% | -61.84M 1.79% | -47.26M 23.57% | |
investments in property plant and equipment | -36.56M - | -38.27M 4.67% | -185.41M 384.51% | -164.49M 11.29% | -27.68M 83.17% | |
acquisitions net | 875K - | 9K 98.97% | -151.18M 1,679,866.67% | -14K 99.99% | ||
purchases of investments | -13.41M - | -18.04M - | ||||
sales maturities of investments | 12.53M - | 18.04M - | ||||
other investing activites | -12.53M - | 422K - | -17.98M 4,361.14% | 22K 100.12% | ||
net cash used for investing activites | -49.09M - | -38.26M 22.07% | -336.17M 778.66% | -182.48M 45.72% | -27.66M 84.84% | |
debt repayment | -15.22M - | -1.94M 87.25% | -27.16M 1,299.38% | -1.50M 94.46% | ||
common stock issued | 8.75M - | 32.52M 271.55% | -890K 102.74% | -236K 73.48% | 225K 195.34% | |
common stock repurchased | -4.60M - | -890K - | -236K 73.48% | |||
dividends paid | -48.25M - | -890K - | ||||
other financing activites | 112.82M - | 392.10M 247.54% | 336.03M 14.30% | 23.73M 92.94% | 83.81M 253.19% | |
net cash used provided by financing activities | 53.50M - | 422.68M 690.08% | 306.20M 27.56% | 21.75M 92.90% | 84.03M 286.31% | |
effect of forex changes on cash | ||||||
net change in cash | 2.73M - | 370.62M 13,465.85% | -92.93M 125.07% | -222.57M 139.50% | 9.10M 104.09% | |
cash at beginning of period | 6.55M - | 9.28M 41.74% | 379.90M 3,994.60% | 286.97M 24.46% | 64.40M 77.56% | |
cash at end of period | 9.28M - | 379.90M 3,994.60% | 286.97M 24.46% | 64.40M 77.56% | 73.50M 14.13% | |
operating cash flow | -1.67M - | -13.80M 724.69% | -62.96M 356.35% | -61.84M 1.79% | -47.26M 23.57% | |
capital expenditure | -36.56M - | -38.27M 4.67% | -185.41M 384.51% | -164.49M 11.29% | -27.68M 83.17% | |
free cash flow | -38.23M - | -52.06M 36.18% | -248.37M 377.05% | -226.32M 8.88% | -74.95M 66.88% |
All numbers in USD (except ratios and percentages)